1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Genomic Biomarker Revenue
• 1.4 Market by Type
  • 1.4.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oncology
  • 1.4.3 Cardiology
  • 1.4.4 Neurology
  • 1.4.5 Nephrology
• 1.5 Market by Application
  • 1.5.1 Global Genomic Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostic and research laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Genomic Biomarker Market Perspective (2015-2026)
• 2.2 Global Genomic Biomarker Growth Trends by Regions
  • 2.2.1 Genomic Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Genomic Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Genomic Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Genomic Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Genomic Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Genomic Biomarker Players by Market Size
  • 3.1.1 Global Top Genomic Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Genomic Biomarker Market Concentration Ratio
  • 3.2.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2019
• 3.3 Genomic Biomarker Key Players Head office and Area Served
• 3.4 Key Players Genomic Biomarker Product Solution and Service
• 3.5 Date of Enter into Genomic Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Genomic Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Genomic Biomarker Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Genomic Biomarker Market Size by Application (2015-2020)
• 5.2 Global Genomic Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Genomic Biomarker Market Size (2015-2020)
• 6.2 Genomic Biomarker Key Players in North America (2019-2020)
• 6.3 North America Genomic Biomarker Market Size by Type (2015-2020)
• 6.4 North America Genomic Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Genomic Biomarker Market Size (2015-2020)
• 7.2 Genomic Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Genomic Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Genomic Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Genomic Biomarker Market Size (2015-2020)
• 8.2 Genomic Biomarker Key Players in China (2019-2020)
• 8.3 China Genomic Biomarker Market Size by Type (2015-2020)
• 8.4 China Genomic Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Genomic Biomarker Market Size (2015-2020)
• 9.2 Genomic Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Genomic Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Genomic Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Genomic Biomarker Market Size (2015-2020)
• 10.2 Genomic Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Genomic Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Genomic Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Genomic Biomarker Market Size (2015-2020)
• 11.2 Genomic Biomarker Key Players in India (2019-2020)
• 11.3 India Genomic Biomarker Market Size by Type (2015-2020)
• 11.4 India Genomic Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Genomic Biomarker Market Size (2015-2020)
• 12.2 Genomic Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Genomic Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Genomic Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bio-Rad
  • 13.1.1 Bio-Rad Company Details
  • 13.1.2 Bio-Rad Business Overview
  • 13.1.3 Bio-Rad Genomic Biomarker Introduction
  • 13.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2015-2020))
  • 13.1.5 Bio-Rad Recent Development
• 13.2 Beckman Coulter
  • 13.2.1 Beckman Coulter Company Details
  • 13.2.2 Beckman Coulter Business Overview
  • 13.2.3 Beckman Coulter Genomic Biomarker Introduction
  • 13.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2015-2020)
  • 13.2.5 Beckman Coulter Recent Development
• 13.3 Myriad Genetics
  • 13.3.1 Myriad Genetics Company Details
  • 13.3.2 Myriad Genetics Business Overview
  • 13.3.3 Myriad Genetics Genomic Biomarker Introduction
  • 13.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2015-2020)
  • 13.3.5 Myriad Genetics Recent Development
• 13.4 Thermo Fisher Scientific
  • 13.4.1 Thermo Fisher Scientific Company Details
  • 13.4.2 Thermo Fisher Scientific Business Overview
  • 13.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
  • 13.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2015-2020)
  • 13.4.5 Thermo Fisher Scientific Recent Development
• 13.5 Roche
  • 13.5.1 Roche Company Details
  • 13.5.2 Roche Business Overview
  • 13.5.3 Roche Genomic Biomarker Introduction
  • 13.5.4 Roche Revenue in Genomic Biomarker Business (2015-2020)
  • 13.5.5 Roche Recent Development
• 13.6 QIAGEN
  • 13.6.1 QIAGEN Company Details
  • 13.6.2 QIAGEN Business Overview
  • 13.6.3 QIAGEN Genomic Biomarker Introduction
  • 13.6.4 QIAGEN Revenue in Genomic Biomarker Business (2015-2020)
  • 13.6.5 QIAGEN Recent Development
• 13.7 Epigenomics
  • 13.7.1 Epigenomics Company Details
  • 13.7.2 Epigenomics Business Overview
  • 13.7.3 Epigenomics Genomic Biomarker Introduction
  • 13.7.4 Epigenomics Revenue in Genomic Biomarker Business (2015-2020)
  • 13.7.5 Epigenomics Recent Development
• 13.8 Almac
  • 13.8.1 Almac Company Details
  • 13.8.2 Almac Business Overview
  • 13.8.3 Almac Genomic Biomarker Introduction
  • 13.8.4 Almac Revenue in Genomic Biomarker Business (2015-2020)
  • 13.8.5 Almac Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview
  • 13.9.3 Pfizer Genomic Biomarker Introduction
  • 13.9.4 Pfizer Revenue in Genomic Biomarker Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Human Longevity
  • 13.10.1 Human Longevity Company Details
  • 13.10.2 Human Longevity Business Overview
  • 13.10.3 Human Longevity Genomic Biomarker Introduction
  • 13.10.4 Human Longevity Revenue in Genomic Biomarker Business (2015-2020)
  • 13.10.5 Human Longevity Recent Development
• 13.11 ValiRx
  • 10.11.1 ValiRx Company Details
  • 10.11.2 ValiRx Business Overview
  • 10.11.3 ValiRx Genomic Biomarker Introduction
  • 10.11.4 ValiRx Revenue in Genomic Biomarker Business (2015-2020)
  • 10.11.5 ValiRx Recent Development
• 13.12 Personalis
  • 10.12.1 Personalis Company Details
  • 10.12.2 Personalis Business Overview
  • 10.12.3 Personalis Genomic Biomarker Introduction
  • 10.12.4 Personalis Revenue in Genomic Biomarker Business (2015-2020)
  • 10.12.5 Personalis Recent Development
• 13.13 Eagle Genomics
  • 10.13.1 Eagle Genomics Company Details
  • 10.13.2 Eagle Genomics Business Overview
  • 10.13.3 Eagle Genomics Genomic Biomarker Introduction
  • 10.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2015-2020)
  • 10.13.5 Eagle Genomics Recent Development
• 13.14 Empire Genomics
  • 10.14.1 Empire Genomics Company Details
  • 10.14.2 Empire Genomics Business Overview
  • 10.14.3 Empire Genomics Genomic Biomarker Introduction
  • 10.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2015-2020)
  • 10.14.5 Empire Genomics Recent Development
• 13.15 Agilent
  • 10.15.1 Agilent Company Details
  • 10.15.2 Agilent Business Overview
  • 10.15.3 Agilent Genomic Biomarker Introduction
  • 10.15.4 Agilent Revenue in Genomic Biomarker Business (2015-2020)
  • 10.15.5 Agilent Recent Development
• 13.16 Illumina
  • 10.16.1 Illumina Company Details
  • 10.16.2 Illumina Business Overview
  • 10.16.3 Illumina Genomic Biomarker Introduction
  • 10.16.4 Illumina Revenue in Genomic Biomarker Business (2015-2020)
  • 10.16.5 Illumina Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Genomic Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina

Market segment by Type, the product can be split into
Oncology
Cardiology
Neurology
Nephrology
Market segment by Application, split into
Hospitals
Diagnostic and research laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America